Wang Lijin, Li Xiaokang, Li Tian, Liu Lin, Wang Haiyan, Wang Chiyao
Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
Front Cardiovasc Med. 2023 Mar 2;10:1055274. doi: 10.3389/fcvm.2023.1055274. eCollection 2023.
The incidence of coronary heart disease (CAD) has soared over the years, and coronary intervention has become an increasingly important therapeutic approach. The past decade has witnessed unprecedented developments in therapeutic medical instruments. Given that drug-coated balloons bring many benefits, they are indicated for an increasing number of conditions. In this article, we review the results of current clinical trials about drug-coated balloons and summarize their safety and clinical progression in different coronary artery diseases, laying the groundwork for basic research, and clinical therapeutics of this patient population.
近年来,冠心病(CAD)的发病率急剧上升,冠状动脉介入治疗已成为一种越来越重要的治疗方法。在过去十年中,治疗性医疗器械取得了前所未有的发展。鉴于药物涂层球囊带来诸多益处,其适用于越来越多的病症。在本文中,我们回顾了关于药物涂层球囊的当前临床试验结果,并总结了它们在不同冠状动脉疾病中的安全性和临床进展,为该患者群体的基础研究和临床治疗奠定基础。